(Q77070095)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12270783%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

review article

1 reference

title

Chemoprevention of superficial bladder cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12270783%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

author name string

Jason Gee

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12270783%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

Anita L Sabichi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12270783%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

H Barton Grossman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12270783%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

publication date

1 September 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12270783%20AND%20SRC:MED&resulttype=core&format=json

Critical Reviews in Oncology Hematology

2 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12270783%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12270783%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

page(s)

277-286

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12270783%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12270783%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

cites work

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Superficial bladder cancer: state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Cancer chemoprevention: progress and promise

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Retinoids in the chemoprevention of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Clonal origin of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Gender- and smoking-related bladder cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Use of markers in defining urothelial premalignant and malignant conditions.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Megadose vitamins in bladder cancer: a double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group. EORTC Genito-Urinary Tract Cancer Coopera

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Dietary factors in cancer of the lower urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Effect of soybean feeding on experimental carcinogenesis--III. Carcinogenecity of nitrite and dibutylamine in mice: a histopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Effects of vitamins C and E on N-nitroso compound formation, carcinogenesis, and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US men

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

TISSUE CHANGES FOLLOWING DEPRIVATION OF FAT-SOLUBLE A VITAMIN

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

13-cis-retinoic acid: inhibition of bladder carcinogenesis in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Differentiation therapy for acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

All-trans-retinoic acid in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Retinoids block phenotypic cell transformation produced by sarcoma growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Dietary risk factors in human bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

The scientific basis for regarding vitamin A and its analogues as anti-carcinogenic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Adjuvant treatment with a vitamin A analogue (etretinate) after transurethral resection of superficial bladder tumors. Final analysis of a prospective, randomized multicenter trial in Switzerland.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Phase IIa study of fenretinide in superficial bladder cancer, using DNA flow cytometry as an intermediate end point

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Time course of fenretinide-induced modulation of circulating insulin-like growth factor (IGF)-i, IGF-II and IGFBP-3 in a bladder cancer chemoprevention trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland).

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Ornithine decarboxylase overexpression in mouse 10T1/2 fibroblasts: cellular transformation and invasion

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

The Role of Soy Products in Reducing Risk of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Soy protein isolate consumption protects against azoxymethane-induced colon tumors in male rats

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Case-control study of phyto-oestrogens and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Cyclooxygenase-2 inhibitors in tumorigenesis (part I)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Induction of NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase expression by androgens in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Chemoprevention by indomethacin of tumor promotion in a rat urinary bladder carcinogenesis model.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

Chemoprevention of superficial bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900190-1

7 January 2021

10.1016/S1040-8428(01)00190-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12270783%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference